The United Bio-technology (hengqin) Co., Ltd.
Clinical trials sponsored by The United Bio-technology (hengqin) Co., Ltd., explained in plain language.
-
New injection tested in fight against obesity
Disease control OngoingThis study is testing whether an investigational injection called UBT251 can help people lose weight and improve related health measures. About 205 overweight or obese adults will receive either the UBT251 injection or a placebo (dummy shot) for 24 weeks. Researchers will primari…
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 03:50 UTC
-
New diabetes shot aims to tame blood sugar
Disease control OngoingThis study is testing a new injectable medication called UBT251 to see if it can help control blood sugar in people with type 2 diabetes. It will involve 211 adults and compare the new injection against a placebo and another standard diabetes drug over 24 weeks. The main goal is …
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC